April 21, 2025 - 18:46

Instagram is set to begin testing artificial intelligence (AI) technology aimed at detecting accounts where teenagers are misrepresenting their age by posing as adults. This initiative, announced by parent company Meta, is part of a broader effort to enhance safety and security on the platform.
The AI system will analyze various user behaviors and account characteristics to identify potential underage users who may be attempting to circumvent age restrictions. This move comes in response to growing concerns about the safety of young users on social media, as well as the potential risks associated with inappropriate content and interactions.
Meta's decision to leverage AI technology reflects its commitment to creating a safer online environment for all users, particularly minors. The testing phase will allow the company to refine its approach and gather insights on the effectiveness of the AI in identifying and addressing this issue. As social media continues to evolve, such measures are crucial in protecting vulnerable demographics.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...